Lidocaine Hydrochloride And Hydrocortisone Acetate Cream
NDC Package 13925-165-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidocaine Hydrochloride And Hydrocortisone Acetate cream is product is used for the anti-inflammatory and anesthetic relief of itching, pain, soreness and discomfort due to hemorrhoids, anal fissures, pruritus ani and similar conditions of the anal area. This formulation utilizes a cream delivery system. Marketed by Seton Pharmaceuticals, this product is identified by NDC 13925-165.

Identification & Billing

NDC Package Code
13925-165-20
Package Description
20 TUBE in 1 KIT / 7 g in 1 TUBE
Product Code
13925-165
11-Digit Billing Format
13925016520
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1012235 - hydrocortisone acetate 0.5 % / lidocaine HCl 3 % Rectal Cream
  • RxCUI: 1012235 - hydrocortisone acetate 5 MG/ML / lidocaine hydrochloride 30 MG/ML Rectal Cream
  • RxCUI: 1012235 - hydrocortisone acetate 0.5 % / lidocaine hydrochloride 3 % Rectal Cream

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride And Hydrocortisone Acetate
Non-Proprietary Name
Lidocaine Hydrochloride And Hydrocortisone Acetate
Substance Name
Hydrocortisone Acetate; Lidocaine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Rectal - Administration to the rectum.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Product is used for the anti-inflammatory and anesthetic relief of itching, pain, soreness and discomfort due to hemorrhoids, anal fissures, pruritus ani and similar conditions of the anal area.

Regulatory & Marketing

Labeler Name
Seton Pharmaceuticals
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-17-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 13925-165-20 identifies a specific commercial package of 20 tube in 1 kit / 7 g in 1 tube of Lidocaine Hydrochloride And Hydrocortisone Acetate, a human prescription drug labeled by Seton Pharmaceuticals. This cream is formulated for rectal use and contains hydrocortisone acetate; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Seton Pharmaceuticals on June 17, 2011. The current certification is valid through December 31, 2026.

How is this Seton Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 13925016520. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
13925-165-20
11-Digit CMS (5-4-2)
13925-0165-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.